Page last updated: 2024-08-21

2-tert-butylhydroquinone and Thrombopenia

2-tert-butylhydroquinone has been researched along with Thrombopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Huang, XJ; Kong, Y; Luo, XY; Lv, M; Mo, XD; Tang, FF; Wang, Y; Xu, LP; Zhang, XH	1

Other Studies

1 other study(ies) available for 2-tert-butylhydroquinone and Thrombopenia

Article	Year
The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation. British journal of haematology, 2023, Volume: 200, Issue:6 Topics: Bone Marrow; Bone Marrow Cells; Case-Control Studies; Hematopoietic Stem Cell Transplantation; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; NF-E2-Related Factor 2; Reactive Oxygen Species; Thrombocytopenia; Transplantation, Homologous	2023

Article

Year

The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.

British journal of haematology, 2023, Volume: 200, Issue:6

Topics: Bone Marrow; Bone Marrow Cells; Case-Control Studies; Hematopoietic Stem Cell Transplantation; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; NF-E2-Related Factor 2; Reactive Oxygen Species; Thrombocytopenia; Transplantation, Homologous

2023